首页> 外国专利> Radicicol derivatives or pharmacologically acceptable salts which show tyrosine kinase inhibition activity and have antitumor effects

Radicicol derivatives or pharmacologically acceptable salts which show tyrosine kinase inhibition activity and have antitumor effects

机译:Radicicol衍生物或药理学上可接受的盐,具有酪氨酸激酶抑制活性并具有抗肿瘤作用

摘要

Radicicol derivatives having an antityrosine kinase activity and represented by general formula (I) or pharmacologically acceptable salts thereof, wherein R1 and R2 are the same or different and each represents hydrogen, alkanoyl, alkenoyl, tert-butyldiphenylsilyl, or tert-butyldimethylsilyl; R3 represents Y- R5 {where Y represents optionally substituted alkylene, R5 represents CONR6R7 (where R6 represents hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted higher alkyl, etc. and R7 represents hydroxy, substituted lower alkyl, etc.), CO2R12 (where R12 represents substituted lower alkyl, optionally substituted higher alkyl, etc.), etc.}; X represents halogeno or is bonded to R4 to represent a single bond; and R4 is bonded to X to represent a single bond or represents hydrogen alkanoyl.
机译:具有通式(I)表示的具有抗酪氨酸激酶活性的雷迪科衍生物或其药理学上可接受的盐,其中R 1和R 2相同或不同,分别代表氢,链烷酰基,链烯酰基,叔丁基二苯基甲硅烷基或叔丁基二甲基甲硅烷基; R 3代表Y-R 5(其中Y代表任选取代的亚烷基,R 5代表CONR6R7(其中R 6代表氢,羟基,任选取代的低级烷基,任选取代的高级烷基等,R 7代表羟基,取代的低级烷基等),CO 2 R 12 (其中R12代表取代的低级烷基,任选地取代的高级烷基等),等等}; X代表卤代基或与R4键合成单键; R4与X键合以表示单键或表示氢烷酰基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号